Bioelectric Medicine Market to Grow at 7.9% CAGR to 2025 - Global Forecast, Trends, Opportunity, Industry Analysis
In coming years, Bioelectric Medicine Market North America is expected to account for largest share. Factors like rising prevalence of arrhythmia, growing prevalence of chronic diseases, high prevalence of hearing loss, expected approvals for retinal impl
(EMAILWIRE.COM, December 07, 2018 ) Electroceuticals/bioelectric medicine market is expected to grow at a CAGR of 7.9% during the forecast period to reach USD 25.20 Billion by 2021 from an estimated USD 17.20 Billion in 2016. The market growth can be attributed to rising geriatric population, regulatory approval for new and advanced electroceuticals, growing investments and funds for the development of novel therapies and electroceuticals, rising prevalence of neurological disorders, and growing prevalence of hearing loss.
Get Free Bioelectric medicine updates now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=588937 .
The high growth of this region can be attributed to the rising adoption of neurostimulation in Japan, increasing cases of diabetes and rapidly aging population in China, increasing prevalence of hearing loss in Asia-Pacific region, increasing geriatric population & high diabetes prevalence in India, conferences on electroceuticals devices in India and Australia, increasing prevalence of Parkinson’s Disease in Singapore, and regulatory approvals of cochlear implants in the Asia-Pacific region.
Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.) are the key players in the global electroceuticals/bioelectric medicine market.
Electroceuticals/bioelectric medicine market, based on type of device, is segmented into implantable electroceuticals devices, & non-invasive electroceuticals devices. Implantable electroceuticals devices segment is expected to account for largest share of the market in 2016. This is mainly attributed to rising research in this industry & collaborations & partnerships to development electroceuticals devices, the implantable electroceuticals devices being used since a long time, these devices providing continuous treatment within body, and providing an environment for easy treatment of patients.
Get Upto 30% Discount Now at https://www.reportsnreports.com/contacts/discount.aspx?name=588937 .
Electroceuticals/bioelectric medicine market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, approvals, new product launches, agreements/collaborations/joint ventures/partnerships, marketing & promotion activities, acquisitions and mergers, expansions, market developments, new program launches, and product enhancements) to increase their market shares and establish a stronger foothold in the global market.
Electroceuticals/Bioelectric Medicine Market, by Product
• Implantable Cardioverter Defibrillators
• Cardiac Pacemakers
• Spinal Cord Stimulators
• Cochlear Implants
• Deep Brain Stimulators
• Transcutaneous Electrical Nerve Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Retinal Implants
• Other Electrical Stimulators
More Information on “Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021” report @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=588937 .
North America is expected to account for largest share of the global electroceuticals/bioelectric medicine market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Electroceuticals are medical devices that use electrical impulses to modulate the body's neural circuits as an alternative to drug-based interventions.
Target Audience:
• Electroceuticals/Bioelectric Medicine Device Manufacturing Companies
• Suppliers and Distributors of Electroceuticals/Bioelectric Medicine Devices
• Healthcare Service Providers
• Teaching Hospitals and Academic Medical Centers (AMCs)
• Health Insurance Players
• Research and Consulting Firm
• Medical Research Institutes
• Audiology Centers
• Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
• Venture Capitalists
• Community Centers
Large share of North American region can be attributed to rising prevalence of arrhythmia, growing prevalence of chronic diseases, expected approvals for retinal implants, increasing regulatory approvals in U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada, among others.
Get Free Bioelectric medicine updates now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=588937 .
The high growth of this region can be attributed to the rising adoption of neurostimulation in Japan, increasing cases of diabetes and rapidly aging population in China, increasing prevalence of hearing loss in Asia-Pacific region, increasing geriatric population & high diabetes prevalence in India, conferences on electroceuticals devices in India and Australia, increasing prevalence of Parkinson’s Disease in Singapore, and regulatory approvals of cochlear implants in the Asia-Pacific region.
Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.) are the key players in the global electroceuticals/bioelectric medicine market.
Electroceuticals/bioelectric medicine market, based on type of device, is segmented into implantable electroceuticals devices, & non-invasive electroceuticals devices. Implantable electroceuticals devices segment is expected to account for largest share of the market in 2016. This is mainly attributed to rising research in this industry & collaborations & partnerships to development electroceuticals devices, the implantable electroceuticals devices being used since a long time, these devices providing continuous treatment within body, and providing an environment for easy treatment of patients.
Get Upto 30% Discount Now at https://www.reportsnreports.com/contacts/discount.aspx?name=588937 .
Electroceuticals/bioelectric medicine market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, approvals, new product launches, agreements/collaborations/joint ventures/partnerships, marketing & promotion activities, acquisitions and mergers, expansions, market developments, new program launches, and product enhancements) to increase their market shares and establish a stronger foothold in the global market.
Electroceuticals/Bioelectric Medicine Market, by Product
• Implantable Cardioverter Defibrillators
• Cardiac Pacemakers
• Spinal Cord Stimulators
• Cochlear Implants
• Deep Brain Stimulators
• Transcutaneous Electrical Nerve Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Retinal Implants
• Other Electrical Stimulators
More Information on “Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021” report @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=588937 .
North America is expected to account for largest share of the global electroceuticals/bioelectric medicine market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Electroceuticals are medical devices that use electrical impulses to modulate the body's neural circuits as an alternative to drug-based interventions.
Target Audience:
• Electroceuticals/Bioelectric Medicine Device Manufacturing Companies
• Suppliers and Distributors of Electroceuticals/Bioelectric Medicine Devices
• Healthcare Service Providers
• Teaching Hospitals and Academic Medical Centers (AMCs)
• Health Insurance Players
• Research and Consulting Firm
• Medical Research Institutes
• Audiology Centers
• Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
• Venture Capitalists
• Community Centers
Large share of North American region can be attributed to rising prevalence of arrhythmia, growing prevalence of chronic diseases, expected approvals for retinal implants, increasing regulatory approvals in U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada, among others.
Contact Information:
ReportsnReports
Ganesh Pardeshi
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Ganesh Pardeshi
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results